The first message to mankind at the dawn of the 21st century was the completion of the gene map of the human genome.

Seeking to learn the entire structure of the human genome, the Human Genome Project has suggested that each gene contains information on the secret of life, proposing a new approach to understanding the biological phenomena. The achievements of the human genome project have rapidly resulted inthe dawning of a new paradigm, with the era of individual, customized medicine and remote diagnosis now becoming a reality, thanks to information on human genes and bioinformatics.

Completing the 21st century medical revolution characterized by regenerative and informatic medicine requires developing a new tool based on genomics. Macrogen has developed fundamental tools for the era of gene medicine from DNA information analysis to functional genomics using bioinformatics infrastructure and has consequently commercialized related products. We have also expanded the range of the genomics industry by developing "Super Alcohol Bacteria," a tool kit used for diagnosing congenital malformations, and genetic disorders etc., through tireless research and development on genomics. We at Macrogen have already commercialized a genetically modified mice production and cloning technology and established MGenbio, Inc., to face a new challenge: xenotransplantation.

"Slowly but Surely"
The directors and employees of Macrogen have taken formidable responsibilities as the industry leader, guided by their boundless vision for the future bio industry. We vow to protect the interest of our shareholders through steady R&D, managerial efficiency, and corporate ethics and contribute to the community as an ideal biotech firm.

Thank you.